KR100530107B1 - 액정막 유화 화장료 조성물 및 그의 제조방법 - Google Patents
액정막 유화 화장료 조성물 및 그의 제조방법 Download PDFInfo
- Publication number
- KR100530107B1 KR100530107B1 KR10-2002-0085832A KR20020085832A KR100530107B1 KR 100530107 B1 KR100530107 B1 KR 100530107B1 KR 20020085832 A KR20020085832 A KR 20020085832A KR 100530107 B1 KR100530107 B1 KR 100530107B1
- Authority
- KR
- South Korea
- Prior art keywords
- liquid crystal
- crystal film
- weight
- emulsion cosmetic
- cosmetic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- 239000000839 emulsion Substances 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title abstract description 7
- 229920000136 polysorbate Polymers 0.000 claims abstract description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 11
- 229950008882 polysorbate Drugs 0.000 claims abstract description 11
- 235000013311 vegetables Nutrition 0.000 claims abstract description 11
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 9
- 239000000194 fatty acid Substances 0.000 claims abstract description 9
- 229930195729 fatty acid Natural products 0.000 claims abstract description 9
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000012071 phase Substances 0.000 claims description 31
- 239000002994 raw material Substances 0.000 claims description 23
- 238000004090 dissolution Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 7
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 6
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 6
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 5
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 claims description 5
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 claims description 5
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 229940057995 liquid paraffin Drugs 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 229940113124 polysorbate 60 Drugs 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 3
- 241000202807 Glycyrrhiza Species 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 229920001219 Polysorbate 40 Polymers 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 229940068977 polysorbate 20 Drugs 0.000 claims description 3
- 229940101027 polysorbate 40 Drugs 0.000 claims description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 claims description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- 239000001570 sorbitan monopalmitate Substances 0.000 claims description 2
- 235000011071 sorbitan monopalmitate Nutrition 0.000 claims description 2
- 229940031953 sorbitan monopalmitate Drugs 0.000 claims description 2
- 229940031439 squalene Drugs 0.000 claims description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 2
- 229940012831 stearyl alcohol Drugs 0.000 claims description 2
- 241000219295 Portulaca Species 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 230000000774 hypoallergenic effect Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- 239000002245 particle Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000004945 emulsification Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 7
- 238000005191 phase separation Methods 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000007957 coemulsifier Substances 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000037384 skin absorption Effects 0.000 description 2
- 231100000274 skin absorption Toxicity 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 229960004418 trolamine Drugs 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- ZZPQSQFQHIGCRC-OOFFSTKBSA-N (2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-c Chemical compound [Zn].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ZZPQSQFQHIGCRC-OOFFSTKBSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- -1 liquid paraffin Chemical compound 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
구분 | 조 성 | 실 시 예 | ||||
1 | 2 | 3 | 4 | 5 | ||
유상 | 세토스테아릴알콜 | 0.5 | 0.5 | 0.5 | 1.0 | 1.5 |
폴리솔베이트 60 | 1.0 | 1.5 | 1.5 | 2.0 | 1.5 | |
스테아린산 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
유동파라핀 | 4.0 | - | - | - | - | |
이소헥사데칸 | - | 4.0 | - | 5.0 | 4.0 | |
스쿠알란 | - | - | 4.0 | - | - | |
에틸헥실펄라고네이트 | 1.0 | 1.0 | 1.0 | 1.0 | 0.5 | |
트리메치올프로판 트리카프릴레이트/트리카프레이트 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | |
디메치콘(100cs) | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
대두오일 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
유용성 방부제 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
수상 | CARBOPOL 941 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
아크릴레이트 복합 폴리머 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
1.3 BG | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | |
2Na-EDTA | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
첨가제 | 향료 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
트리에탄올 아민 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
마치현 추출물 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
감초산 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
수용성 방부제 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
정제수 | to 100 | to 100 | to 100 | to 100 | to 100 | |
사용감 | 2 | 2 | 1 | 3 | 4 | |
백탁현상 | 1 | 1 | 1 | 1 | 1 | |
액정형성 | 2 | 1 | 2 | 3 | 3 | |
안정성 | 2 | 1 | 1 | 1 | 3 |
구분 | 조 성 | 비 교 예 | ||||
1 | 2 | 3 | 4 | 5 | ||
유상 | 세탄올 | 0.5 | 0.5 | 0.7 | 1.0 | 1.0 |
스테아린산 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
폴리솔베이트 60 | 1.5 | - | - | 2.0 | 2.0 | |
폴리솔베이트 40 | - | 1.5 | - | - | - | |
폴리솔베이트 20 | - | - | 1.5 | - | - | |
유동파라핀 | 5.0 | 4.0 | 4.0 | 4.0 | 4.0 | |
세테아릴 옥타노에이트 | 3.0 | - | - | - | - | |
카프릴/카프릴릭/트리에칠글리세라이드 | 2.0 | 5.0 | 5.0 | 5.0 | 5.0 | |
디메치콘(100cs) | - | - | - | - | - | |
대두오일 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | |
유용성 방부제 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
수상 | CARBOPOL 941 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
아크릴레이트 복합 폴리머 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
1.3 BG | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | |
2Na-EDTA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
첨가제상 | 향료 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
트리에탄올 아민 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
수용성 방부제 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
정제수 | to 100 | to 100 | to 100 | to 100 | to 100 | |
사용감 | 2 | 3 | 3 | 4 | 4 | |
백탁현상 | 2 | 2 | 2 | 4 | 4 | |
액정형성 | 2 | 3 | 3 | 2 | 2 | |
안정성 | 2 | 3 | 3 | 1 | 1 |
구분 | 48시간 후 | 72시간 후 | 반응도(n=30) | ||||||||||
0.5± | 1+ | 2+ | 3+ | 4+ | 0.5± | 1+ | 2+ | 3+ | 4+ | 48시간 | 72시간 | 평균 | |
실시예 1 | 2명 | - | - | - | - | 1명 | - | - | - | - | 0.8 | 0.4 | 0.6 |
실시예 2 | 1명 | - | - | - | - | 1명 | - | - | - | - | 0.4 | 0.4 | 0.4 |
0 : 음성, 정상 피부 0.5±: 약간의 의심스러운 홍반 1+ : 한정적인 홍반 2+ : 홍반 & 경변 3+ : 소포형성 4+ : 수포성 반응 |
온도 기간 | 1주 | 2주 | 4주 | 3개월 | 6개월 |
-5 ℃ | 1 | 1 | 1 | 1 | 1 |
25 ℃ | 1 | 1 | 1 | 1 | 1 |
40 ℃ | 1 | 1 | 1 | 2 | 3 |
50 ℃ | 1 | 1 | 1 | 3 | 4 |
매우 안정(점도, pH, 입자크기 변함없음): 1 다소안정(점도, pH, 입자크기 일부변화 있으나 안정도 영향 없음): 2 보통(점도, pH, 입자크기에 변화가 생겼으나 상분리는 일어나지 않음: 3 다소 불안정 (점도, pH, 입자크기의 현격한 변화가 생겨 상분리의 조짐: 4 매우 불안정 (상분리) : 5 |
Claims (6)
- 유상부, 수상부, 첨가제로 이루어진 액정막 유화 화장료 조성물에 있어서, 상기 유상부는 폴리옥시에틸렌 소르비탄 모노라우레이트(polyoxyethylene sorbitan monolaurate, 폴리솔베이트 20), 폴리옥시에틸렌 소르비탄 모노팔미테이트(ne sorbitan monopalmitate, 폴리솔베이트 40) 및 폴리옥시에틸렌 소르비탄 모노스테아레이트(polyoxyethylene sorbitan monostearate, 폴리솔베이트 60) 중에서 선택된 1종 이상의 식물성 폴리솔베이트 계면활성제 1 ~ 10 중량%; 스테아린산 및 팔미탄산 중에서 선택된 1종 이상의 지방산 0.1 ~ 10 중량%; 세탄올, 세토스테아릴알콜 및 스테아릴알콜 중에서 선택된 1종 이상의 고급 알코올 0.1 ~ 10 중량%; 및 이소헥사데칸, 헥사데칸, 스쿠알렌, 유동파라핀 및 피토스쿠알렌 중에서 선택된 1종 이상의 비극성 오일 1.0 ~ 10 중량%를 포함하는 것을 특징으로 하는 액정막 유화 화장료 조성물.
- 제 1 항에 있어서, 상기 식물성 폴리솔베이트 계면활성제, 지방산, 고급 알코올 및 비극성 오일의 친유부 탄소수가 서로 일치하는 것을 특징으로 하는 액정막 유화 화장료 조성물.
- 삭제
- 제 1 항 또는 제 2 항에 있어서, 상기 조성은 추가적으로 감초산 및 마치현 추출물을 포함하는 것을 특징으로 하는 액정막 유화 화장료 조성물.
- 제 4 항에 있어서, 상기 감초산 및 마치현 추출물은 전체 조성물 함량 중 각각 0.01 ∼ 2.0 중량%인 것을 특징으로 하는 액정막 유화 화장료 조성물.
- 제 1 항의 조성을 포함하는 유상부의 원료를 70 ∼ 90 ℃까지 가온하여 유상부를 용해시키는 단계;별도의 용해조에 수상부의 원료를 순차적으로 투입하고 70 ∼ 90 ℃까지 가온하여 수상부 원료를 분산시키는 단계;액화된 유상부 용해조의 온도를 유지한 채 유상부에 수상부의 원료를 투입하여 2500 ∼ 3500rpm으로 교반하는 1차 혼합단계;혼합 용해조의 온도를 40 ∼ 50 ℃로 냉각한 후 첨가제를 순차적으로 투입하여 5 ∼ 20rpm으로 천천히 교반하는 2차 혼합단계; 및상기 혼합 용해조를 25 ∼ 35 ℃까지 냉각하여 탈포시키는 단계를 포함하는 것을 특징으로 하는 액정막 유화 화장료의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0085832A KR100530107B1 (ko) | 2002-12-28 | 2002-12-28 | 액정막 유화 화장료 조성물 및 그의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0085832A KR100530107B1 (ko) | 2002-12-28 | 2002-12-28 | 액정막 유화 화장료 조성물 및 그의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040059245A KR20040059245A (ko) | 2004-07-05 |
KR100530107B1 true KR100530107B1 (ko) | 2005-11-22 |
Family
ID=37351269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0085832A Expired - Lifetime KR100530107B1 (ko) | 2002-12-28 | 2002-12-28 | 액정막 유화 화장료 조성물 및 그의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100530107B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190016812A (ko) | 2017-08-09 | 2019-02-19 | 주식회사 엘지생활건강 | 유화제 조합으로 점도를 컨트롤하는 액정유화 조성물 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101404968B1 (ko) * | 2007-08-14 | 2014-06-13 | (주)아모레퍼시픽 | 액정 형성 복합체를 함유하는 피부 보습 증진용 또는 각질감소용 화장료 조성물 |
-
2002
- 2002-12-28 KR KR10-2002-0085832A patent/KR100530107B1/ko not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190016812A (ko) | 2017-08-09 | 2019-02-19 | 주식회사 엘지생활건강 | 유화제 조합으로 점도를 컨트롤하는 액정유화 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20040059245A (ko) | 2004-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Friberg | Micelles, microemulsions, liquid crystals, and the structure of stratum corneum lipids | |
DE69327527T2 (de) | Verfahren zur herstellung einer mehrphasenzusammensetzung | |
US4803067A (en) | Compositions for cosmetics and dermatology comprising perfluoropolyethers | |
KR101547528B1 (ko) | 유중수형 피커링 에멀젼 화장료 조성물 및 이의 제조방법 | |
DE69715065T2 (de) | Ethylcellulose enthältende kosmetische W/O-Emulsion | |
DE60100140T2 (de) | Wasser-in-Öl-Emulsion und ihre Verwendungen insbesondere in der Kosmetik | |
DE60013512T2 (de) | Feste Zusammensetzung und ihre Verwendungen insbesondere in der Kosmetik | |
KR100874877B1 (ko) | 폴리올중유형 고밀집 나노 농축 에멀젼을 이용한유중수중유형 역상 다중 에멀젼 상의 화장료 조성물 및 그제조방법 | |
KR101492290B1 (ko) | 베시클 조성물, 및 피부 외용제 | |
JP2009234971A (ja) | 水中油型乳化化粧料 | |
JPH1112125A (ja) | 界面活性剤を含むパーソナルケア組成物 | |
KR20060041308A (ko) | 안정한 농형 및 담형 수중유형 에멀젼 | |
KR102044908B1 (ko) | 투명성이 개선된 고함량 천연 오일을 함유한 나노 에멀젼 조성물, 이를 포함하는 화장료 조성물 및 이의 제조 방법 | |
KR20130011800A (ko) | 피부 유사 지질을 포함하는 수중유형 유화 조성물 및 이를 포함하는 화장료 조성물 | |
JP4049216B2 (ja) | 液晶構造を有する製剤 | |
JPH0251665B2 (ko) | ||
JPS63126543A (ja) | マイクロエマルシヨン | |
KR20160082054A (ko) | 유화제를 함유하지 않는 수중유 유화형 화장료 조성물 및 이의 제조방법 | |
KR100530107B1 (ko) | 액정막 유화 화장료 조성물 및 그의 제조방법 | |
CN113301964A (zh) | 含有卵磷脂的化妆品基剂及配合有该化妆品基剂的化妆品 | |
KR100570497B1 (ko) | 나노크기의 다중액정막으로 캡슐화된 순수 레티놀을포함하는 주름방지용 화장료 조성물과 이의 제조방법 | |
US9987215B2 (en) | Structuring of cosmetic compostion using organogels | |
JP3535583B2 (ja) | 透明化粧水 | |
KR20170057436A (ko) | 분산 형태의 화장용 및/또는 약학적 조성물, 이의 제조 방법 및 피부 치료용 이의 용도 | |
JP2002302414A (ja) | スフィンゴ脂質構造物質含有乳化組成物及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20021228 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20050131 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20050816 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20051114 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20051115 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20080909 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20090910 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20100927 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20111005 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20121002 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20121002 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130910 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20130910 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150911 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20150911 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170911 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20170911 Start annual number: 13 End annual number: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180910 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20180910 Start annual number: 14 End annual number: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190918 Year of fee payment: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20190918 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20200922 Start annual number: 16 End annual number: 16 |
|
PR1001 | Payment of annual fee |
Payment date: 20211102 Start annual number: 17 End annual number: 17 |
|
PR1001 | Payment of annual fee |
Payment date: 20221115 Start annual number: 18 End annual number: 18 |
|
PC1801 | Expiration of term |
Termination date: 20230628 Termination category: Expiration of duration |